Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

近日，美国食品药品监督管理局（FDA）正式批准了由吉利德（Gilead）公司研发的全新艾滋病病毒（HIV）预防药物——来那卡帕韦（Lenacapavir）。这款 ...

艾滋病（AIDS，获得性免疫缺陷综合征）是一种危害极大的传染性疾病，由人类免疫缺陷病毒（HIV，也叫做艾滋病病毒）感染引起，于20世纪80年代首次被发现，一度被视为“绝症”。HIV主要有两种亚型，即HIV-1和HIV-2，相对来讲，HIV-1的复制能 ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

红枫湾APP： firstwordpharma.com消息，默沙东 (也译为默克）的一款长效（ 每月1次 ） 口服 HIV预防药物也宣布进入后期（III期）试验阶段，即将为HIV PrEP（暴露前预防）再添新选择。

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

距离lenacapavir用于HIV预防在美国获批仅8个工作日，这一国际领先的创新药物就在博鳌乐城实现了“全球同步”准入，以“零时差”完成从海外获批到 ...

The introduction of a revolutionary drug, Lenacapavir, is poised to alter the landscape of healthcare across sub-Saharan ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.